BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24521511)

  • 1. Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability.
    Plein A; Fantin A; Ruhrberg C
    Microcirculation; 2014 May; 21(4):315-23. PubMed ID: 24521511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
    Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
    Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin ligands in vascular and neuronal patterning.
    Fantin A; Maden CH; Ruhrberg C
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1228-32. PubMed ID: 19909252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.
    Fantin A; Herzog B; Mahmoud M; Yamaji M; Plein A; Denti L; Ruhrberg C; Zachary I
    Development; 2014 Feb; 141(3):556-62. PubMed ID: 24401374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.
    Raimondi C
    Biochem Soc Trans; 2014 Oct; 42(5):1429-34. PubMed ID: 25233427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin regulation of angiogenesis.
    Lampropoulou A; Ruhrberg C
    Biochem Soc Trans; 2014 Dec; 42(6):1623-8. PubMed ID: 25399580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neuropilin in vascular and tumor biology.
    Klagsbrun M; Takashima S; Mamluk R
    Adv Exp Med Biol; 2002; 515():33-48. PubMed ID: 12613541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
    Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
    Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective requirements for NRP1 ligands during neurovascular patterning.
    Vieira JM; Schwarz Q; Ruhrberg C
    Development; 2007 May; 134(10):1833-43. PubMed ID: 17428830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
    J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
    Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
    Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.
    Gioelli N; Maione F; Camillo C; Ghitti M; Valdembri D; Morello N; Darche M; Zentilin L; Cagnoni G; Qiu Y; Giacca M; Giustetto M; Paques M; Cascone I; Musco G; Tamagnone L; Giraudo E; Serini G
    Sci Transl Med; 2018 May; 10(442):. PubMed ID: 29794061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
    Baek DS; Kim JH; Kim YJ; Kim YS
    Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin 1 Regulation of Vascular Permeability Signaling.
    Domingues A; Fantin A
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 Acts as a Receptor for Complement Split Products.
    Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
    Front Immunol; 2019; 10():2209. PubMed ID: 31572401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the neuropilin ligands VEGF164 and SEMA3A in neuronal and vascular patterning in the mouse.
    Vieira JM; Schwarz Q; Ruhrberg C
    Novartis Found Symp; 2007; 283():230-5; discussion 235-41. PubMed ID: 18300426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.
    Lanahan A; Zhang X; Fantin A; Zhuang Z; Rivera-Molina F; Speichinger K; Prahst C; Zhang J; Wang Y; Davis G; Toomre D; Ruhrberg C; Simons M
    Dev Cell; 2013 Apr; 25(2):156-68. PubMed ID: 23639442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.